Unilever was among the existing investors that supplied $22.9m for meal kit provider Gousto, increasing its funding to about $100m to date.

The Century Internet-backed broadband network technology provider has raised $14.6m in a round led by Qualcomm Ventures.

Based on research from the universities of Bristol and Nottingham, Exonate has now raised $9m to develop a topical eye drop for conditions including diabetic macular edema.

Lidar technology developer Baraja has lured the support of Csiro's Innovation Fund as it pursues additional business for its autonomous vehicle perception system in the US and Asia.

Autoimmune disease therapy spinout Cabaletta Bio's series B round brought its total to at least $88m allowed the university to pare back its shareholding.

Tokyo Century has now invested a total of $175m in Grab, helping to boost the ride hailing service’s ongoing series H round to more than $3bn.

Ctrip and Japan Airlines-backed supersonic aircraft developer Boom has completed a $100m series B round that brought its total funding to more than $140m.

Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.

Medical device developer Ablative Solutions has closed the first tranche of its series D round having secured an undisclosed corporate backer.

Investors including Nan Fung and Tekla Capital have increased the ophthalmic treatment developer's series B round to $35.9m, following a Novartis-led tranche a year ago.